Literature DB >> 14532158

Signal transduction networks in rheumatoid arthritis.

D Hammaker1, S Sweeney, G S Firestein.   

Abstract

Signal transduction pathways regulate cellular responses to stress and play a critical role in inflammation. The complexity and specificity of signalling mechanisms represent major hurdles for developing effective, safe therapeutic interventions that target specific molecules. One approach is to dissect the pathways methodically to determine their hierarchy in various cell types and diseases. This approach contributed to the identification and prioritisation of specific kinases that regulate NF-kappa B and the mitogen activated protein (MAP) kinase cascade as especially attractive targets. Although significant issues remain with regard to the discovery of truly selective kinase inhibitors, the risks that accompany inhibition of fundamental signal transduction mechanisms can potentially be decreased by careful dissection of the pathways and rational target selection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532158      PMCID: PMC1766749          DOI: 10.1136/ard.62.suppl_2.ii86

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

Review 1.  NF-kappaB: a key role in inflammatory diseases.

Authors:  P P Tak; G S Firestein
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

Authors:  J W Fijen; J G Zijlstra; P De Boer; R Spanjersberg; J W Tervaert; T S Van Der Werf; J J Ligtenberg; J E Tulleken
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

4.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation.

Authors:  I Lavon; I Goldberg; S Amit; L Landsman; S Jung; B Z Tsuberi; I Barshack; J Kopolovic; E Galun; H Bujard; Y Ben-Neriah
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

6.  Jun N-terminal kinase in rheumatoid arthritis.

Authors:  Z Han; D L Boyle; K R Aupperle; B Bennett; A M Manning; G S Firestein
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

7.  MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.

Authors:  A Kotlyarov; A Neininger; C Schubert; R Eckert; C Birchmeier; H D Volk; M Gaestel
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

8.  Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.

Authors:  Y Fleming; C G Armstrong; N Morrice; A Paterson; M Goedert; P Cohen
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

9.  Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.

Authors:  G Schett; M Tohidast-Akrad; J S Smolen; B J Schmid; C W Steiner; P Bitzan; P Zenz; K Redlich; Q Xu; G Steiner
Journal:  Arthritis Rheum       Date:  2000-11

10.  NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes.

Authors:  K Aupperle; B Bennett; Z Han; D Boyle; A Manning; G Firestein
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

View more
  28 in total

1.  HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients.

Authors:  Haobo Lin; Youjun Xiao; Guoqiang Chen; Di Fu; Yujin Ye; Liuqin Liang; Jinjin Fan; Xiuyan Yang; Lin Sun; Hanshi Xu
Journal:  Rheumatol Int       Date:  2010-05-15       Impact factor: 2.631

2.  Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.

Authors:  Patricia G Oliveira; Ricard Garcia-Carbonell; Adam P Croft; Marta F Bustamante; Jeff M Smith; Ramon L Serrano; Elsa Sanchez-Lopez; Xiao Liu; Tatiana Kisseleva; Nissim Hay; Christopher D Buckley; Gary S Firestein; Anne N Murphy; Shigeki Miyamoto; Monica Guma
Journal:  Ann Rheum Dis       Date:  2018-07-30       Impact factor: 19.103

Review 3.  [Pain in rheumatic diseases : What can biologics and JAK inhibitors offer?]

Authors:  G Pongratz
Journal:  Z Rheumatol       Date:  2021-01-14       Impact factor: 1.372

4.  A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes.

Authors:  Terry A McNearney; Yinghong Ma; Yueping Chen; Giulio Taglialatela; Huaizhi Yin; Wen-Ru Zhang; Karin N Westlund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

5.  A comprehensive molecular interaction map for rheumatoid arthritis.

Authors:  Gang Wu; Lisha Zhu; Jennifer E Dent; Christine Nardini
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

6.  Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  Siqi Xu; Youjun Xiao; Shan Zeng; Yaoyao Zou; Qian Qiu; Mingcheng Huang; Zhongping Zhan; Liuqin Liang; Xiuyan Yang; Hanshi Xu
Journal:  Inflamm Res       Date:  2017-11-08       Impact factor: 4.575

Review 7.  Cell therapy for autoimmune diseases: does it have a future?

Authors:  A Radbruch; A Thiel
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.

Authors:  Tejas S Lahoti; Kaarthik John; Jarod M Hughes; Ann Kusnadi; Iain A Murray; Gowdahalli Krishnegowda; Shantu Amin; Gary H Perdew
Journal:  Ann Rheum Dis       Date:  2013-01-24       Impact factor: 19.103

9.  Effect and mechanism of AR-6 in experimental rheumatoid arthritis.

Authors:  Shi-xue Sun; Yun-man Li; Wei-rong Fang; Peng Cheng; Lifang Liu; Fengwen Li
Journal:  Clin Exp Med       Date:  2009-10-20       Impact factor: 3.984

10.  MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice.

Authors:  L S Sorkin; D L Boyle; D Hammaker; D S Herman; E Vail; G S Firestein
Journal:  Neuroscience       Date:  2009-05-08       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.